Annual CFI
$0.00
+$47.00 K+100.00%
December 31, 2023
Summary
- As of February 7, 2025, FRTX annual cash flow from investing activities is $0.00, with the most recent change of +$47.00 thousand (+100.00%) on December 31, 2023.
- During the last 3 years, FRTX annual CFI has fallen by -$4.48 million (-100.00%).
- FRTX annual CFI is now -100.00% below its all-time high of $42.93 million, reached on December 1, 2007.
Performance
FRTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
$0.000.00%
December 31, 2023
Summary
- As of February 7, 2025, FRTX quarterly cash flow from investing activities is $0.00, unchanged on December 31, 2023.
- Over the past year, FRTX quarterly CFI has stayed the same.
- FRTX quarterly CFI is now -100.00% below its all-time high of $30.40 million, reached on March 1, 2001.
Performance
FRTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$0.00
$0.000.00%
December 31, 2023
Summary
- As of February 7, 2025, FRTX TTM cash flow from investing activities is $0.00, unchanged on December 31, 2023.
- Over the past year, FRTX TTM CFI has stayed the same.
- FRTX TTM CFI is now -100.00% below its all-time high of $52.55 million, reached on September 1, 2001.
Performance
FRTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
FRTX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | 0.0% | 0.0% |
| 3 y3 years | -100.0% | 0.0% | 0.0% |
| 5 y5 years | -100.0% | 0.0% | 0.0% |
FRTX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +100.0% | at high | +100.0% | at high | +100.0% |
| 5 y | 5-year | -100.0% | +100.0% | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | -100.0% | +100.0% | -100.0% | +100.0% | -100.0% | +100.0% |
Fresh Tracks Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2022 | -$47.00 K(+30.6%) | $0.00(-100.0%) | -$47.00 K(0.0%) |
| Sep 2022 | - | -$47.00 K(<-9900.0%) | -$47.00 K(+30.6%) |
| Dec 2021 | -$36.00 K(-100.8%) | - | - |
| Dec 2021 | - | $0.00(0.0%) | -$36.00 K(-39.0%) |
| Sep 2021 | - | $0.00(-100.0%) | -$59.00 K(0.0%) |
| Jun 2021 | - | $4000.00(-110.0%) | -$59.00 K(-6.3%) |
| Mar 2021 | - | -$40.00 K(+73.9%) | -$63.00 K(-101.4%) |
| Dec 2020 | $4.48 M(-86.2%) | -$23.00 K(<-9900.0%) | $4.48 M(-75.8%) |
| Sep 2020 | - | $0.00(0.0%) | $18.50 M(-35.2%) |
| Jun 2020 | - | $0.00(-100.0%) | $28.57 M(-22.8%) |
| Mar 2020 | - | $4.50 M(-67.9%) | $37.01 M(+13.8%) |
| Dec 2019 | $32.51 M(+2435.9%) | $14.00 M(+39.0%) | $32.51 M(+57.3%) |
| Sep 2019 | - | $10.07 M(+19.3%) | $20.66 M(+30.3%) |
| Jun 2019 | - | $8.44 M(<-9900.0%) | $15.86 M(+38.6%) |
| Mar 2019 | - | -$2000.00(-100.1%) | $11.44 M(+792.7%) |
| Dec 2018 | $1.28 M(-124.2%) | $2.15 M(-59.1%) | $1.28 M(-109.2%) |
| Sep 2018 | - | $5.27 M(+30.9%) | -$13.98 M(-4.5%) |
| Jun 2018 | - | $4.02 M(-139.6%) | -$14.64 M(-12.5%) |
| Mar 2018 | - | -$10.16 M(-22.4%) | -$16.73 M(+216.3%) |
| Dec 2017 | -$5.29 M(-31.0%) | -$13.11 M(-384.5%) | -$5.29 M(-184.9%) |
| Sep 2017 | - | $4.61 M(+138.7%) | $6.24 M(+1789.4%) |
| Jun 2017 | - | $1.93 M(+51.0%) | $330.00 K(-158.9%) |
| Mar 2017 | - | $1.28 M(-180.9%) | -$560.00 K(-92.7%) |
| Dec 2016 | -$7.67 M(<-9900.0%) | -$1.58 M(+21.6%) | -$7.67 M(-19.3%) |
| Sep 2016 | - | -$1.30 M(-224.9%) | -$9.50 M(+2.3%) |
| Jun 2016 | - | $1.04 M(-117.8%) | -$9.29 M(+57.9%) |
| Mar 2016 | - | -$5.83 M(+71.2%) | -$5.88 M(<-9900.0%) |
| Dec 2015 | $11.00 K(-100.1%) | -$3.41 M(+213.8%) | $11.00 K(-99.7%) |
| Sep 2015 | - | -$1.09 M(-124.4%) | $3.71 M(-180.6%) |
| Jun 2015 | - | $4.45 M(+7567.2%) | -$4.61 M(-72.4%) |
| Mar 2015 | - | $58.00 K(-80.3%) | -$16.68 M(+34.2%) |
| Dec 2014 | -$12.43 M(-149.4%) | $294.00 K(-103.1%) | -$12.43 M(+71.4%) |
| Sep 2014 | - | -$9.41 M(+23.4%) | -$7.25 M(-273.5%) |
| Jun 2014 | - | -$7.62 M(-276.9%) | $4.18 M(-76.2%) |
| Mar 2014 | - | $4.31 M(-21.3%) | $17.54 M(-30.2%) |
| Dec 2013 | $25.14 M(-193.2%) | $5.47 M(+170.9%) | $25.14 M(+62.8%) |
| Sep 2013 | - | $2.02 M(-64.8%) | $15.44 M(+192.0%) |
| Jun 2013 | - | $5.74 M(-51.8%) | $5.29 M(-185.3%) |
| Mar 2013 | - | $11.91 M(-381.8%) | -$6.20 M(-77.0%) |
| Dec 2012 | -$26.99 M(+435.5%) | -$4.23 M(-48.0%) | -$26.99 M(+31.2%) |
| Sep 2012 | - | -$8.13 M(+41.4%) | -$20.57 M(+71.6%) |
| Jun 2012 | - | -$5.75 M(-35.2%) | -$11.99 M(+593.8%) |
| Mar 2012 | - | -$8.87 M(-506.3%) | -$1.73 M(-65.7%) |
| Dec 2011 | -$5.04 M(-140.3%) | $2.18 M(+383.2%) | -$5.04 M(+77.5%) |
| Sep 2011 | - | $452.00 K(-90.0%) | -$2.84 M(-146.7%) |
| Jun 2011 | - | $4.51 M(-137.0%) | $6.08 M(+105.4%) |
| Mar 2011 | - | -$12.19 M(-378.0%) | $2.96 M(-76.3%) |
| Dec 2010 | $12.51 M(-234.7%) | $4.38 M(-53.2%) | $12.51 M(+5.1%) |
| Sep 2010 | - | $9.37 M(+574.3%) | $11.90 M(-445.1%) |
| Jun 2010 | - | $1.39 M(-152.6%) | -$3.45 M(-69.8%) |
| Mar 2010 | - | -$2.64 M(-169.8%) | -$11.42 M(+23.0%) |
| Dec 2009 | -$9.28 M(-158.3%) | $3.78 M(-163.2%) | -$9.28 M(-38.2%) |
| Sep 2009 | - | -$5.98 M(-9.1%) | -$15.01 M(+126.4%) |
| Jun 2009 | - | -$6.58 M(+1202.6%) | -$6.63 M(-501.2%) |
| Mar 2009 | - | -$505.00 K(-74.1%) | $1.65 M(-89.6%) |
| Dec 2008 | $15.92 M(-62.9%) | -$1.95 M(-181.2%) | $15.92 M(-19.1%) |
| Sep 2008 | - | $2.40 M(+40.7%) | $19.69 M(-44.7%) |
| Jun 2008 | - | $1.71 M(-87.6%) | $35.60 M(-29.3%) |
| Mar 2008 | - | $13.77 M(+657.2%) | $50.38 M(+17.4%) |
| Dec 2007 | $42.93 M | $1.82 M(-90.1%) | $42.93 M(+123.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2007 | - | $18.32 M(+11.1%) | $19.21 M(-348.8%) |
| Jun 2007 | - | $16.48 M(+161.1%) | -$7.72 M(-68.1%) |
| Mar 2007 | - | $6.31 M(-128.8%) | -$24.22 M(+12.6%) |
| Dec 2006 | -$21.51 M(+219.2%) | -$21.91 M(+154.4%) | -$21.51 M(-16.1%) |
| Sep 2006 | - | -$8.61 M(>+9900.0%) | -$25.64 M(+301.0%) |
| Jun 2006 | - | -$15.00 K(-100.2%) | -$6.39 M(+562.5%) |
| Mar 2006 | - | $9.02 M(-134.6%) | -$965.00 K(-85.7%) |
| Dec 2005 | -$6.74 M(-184.5%) | -$26.03 M(-344.8%) | -$6.74 M(-153.0%) |
| Sep 2005 | - | $10.63 M(+96.5%) | $12.73 M(-42.6%) |
| Jun 2005 | - | $5.41 M(+66.9%) | $22.16 M(+17.5%) |
| Mar 2005 | - | $3.24 M(-149.4%) | $18.86 M(+136.5%) |
| Dec 2004 | $7.98 M(-559.3%) | -$6.56 M(-132.7%) | $7.98 M(+15.7%) |
| Sep 2004 | - | $20.06 M(+846.6%) | $6.89 M(+1667.0%) |
| Jun 2004 | - | $2.12 M(-127.7%) | $390.20 K(-75.3%) |
| Mar 2004 | - | -$7.64 M(-0.0%) | $1.58 M(-190.9%) |
| Dec 2003 | -$1.74 M(-118.1%) | -$7.65 M(-156.4%) | -$1.74 M(-106.9%) |
| Sep 2003 | - | $13.56 M(+309.8%) | $25.23 M(+22.5%) |
| Jun 2003 | - | $3.31 M(-130.2%) | $20.60 M(+133.6%) |
| Mar 2003 | - | -$10.96 M(-156.7%) | $8.82 M(-8.3%) |
| Dec 2002 | $9.62 M(-72.8%) | $19.32 M(+116.3%) | $9.62 M(-134.8%) |
| Sep 2002 | - | $8.93 M(-205.4%) | -$27.66 M(+86.6%) |
| Jun 2002 | - | -$8.47 M(-16.6%) | -$14.82 M(+187.0%) |
| Mar 2002 | - | -$10.16 M(-43.4%) | -$5.16 M(-114.6%) |
| Dec 2001 | $35.40 M(-133.4%) | -$17.96 M(-182.5%) | $35.40 M(-32.6%) |
| Sep 2001 | - | $21.77 M(+1734.5%) | $52.55 M(+242.6%) |
| Jun 2001 | - | $1.19 M(-96.1%) | $15.34 M(-202.5%) |
| Mar 2001 | - | $30.40 M(-3849.7%) | -$14.96 M(-85.9%) |
| Dec 2000 | -$106.05 M(>+9900.0%) | -$810.80 K(-94.7%) | -$106.05 M(+1.5%) |
| Sep 2000 | - | -$15.44 M(-47.0%) | -$104.44 M(+21.0%) |
| Jun 2000 | - | -$29.11 M(-52.0%) | -$86.30 M(+59.8%) |
| Mar 2000 | - | -$60.69 M(-7686.4%) | -$53.99 M(+7613.0%) |
| Dec 1999 | -$700.00 K(-110.8%) | $800.00 K(-70.4%) | -$700.00 K(-800.0%) |
| Sep 1999 | - | $2.70 M(-15.6%) | $100.00 K(-96.2%) |
| Jun 1999 | - | $3.20 M(-143.2%) | $2.60 M(-252.9%) |
| Mar 1999 | - | -$7.40 M(-562.5%) | -$1.70 M(-126.2%) |
| Dec 1998 | $6.50 M(+1525.0%) | $1.60 M(-69.2%) | $6.50 M(-7.1%) |
| Sep 1998 | - | $5.20 M(-572.7%) | $7.00 M(+180.0%) |
| Jun 1998 | - | -$1.10 M(-237.5%) | $2.50 M(+56.3%) |
| Mar 1998 | - | $800.00 K(-61.9%) | $1.60 M(+300.0%) |
| Dec 1997 | $400.00 K(-96.0%) | $2.10 M(+200.0%) | $400.00 K(-95.5%) |
| Sep 1997 | - | $700.00 K(-135.0%) | $8.80 M(+12.8%) |
| Jun 1997 | - | -$2.00 M(+400.0%) | $7.80 M(-25.0%) |
| Mar 1997 | - | -$400.00 K(-103.8%) | $10.40 M(+5.1%) |
| Dec 1996 | $9.90 M(-149.7%) | $10.50 M(-3600.0%) | $9.90 M(-134.1%) |
| Sep 1996 | - | -$300.00 K(-150.0%) | -$29.00 M(+5.8%) |
| Jun 1996 | - | $600.00 K(-166.7%) | -$27.40 M(+26.3%) |
| Mar 1996 | - | -$900.00 K(-96.8%) | -$21.70 M(+9.0%) |
| Dec 1995 | -$19.90 M(-482.7%) | -$28.40 M(-2284.6%) | -$19.90 M(-305.2%) |
| Sep 1995 | - | $1.30 M(-79.4%) | $9.70 M(-8.5%) |
| Jun 1995 | - | $6.30 M(+600.0%) | $10.60 M(+116.3%) |
| Mar 1995 | - | $900.00 K(-25.0%) | $4.90 M(-5.8%) |
| Dec 1994 | $5.20 M(-116.3%) | $1.20 M(-45.5%) | $5.20 M(-119.0%) |
| Sep 1994 | - | $2.20 M(+266.7%) | -$27.40 M(-8.1%) |
| Jun 1994 | - | $600.00 K(-50.0%) | -$29.80 M(-2.3%) |
| Mar 1994 | - | $1.20 M(-103.8%) | -$30.50 M(-4.4%) |
| Dec 1993 | -$31.90 M(>+9900.0%) | -$31.40 M(>+9900.0%) | -$31.90 M(+6280.0%) |
| Sep 1993 | - | -$200.00 K(+100.0%) | -$500.00 K(+66.7%) |
| Jun 1993 | - | -$100.00 K(-50.0%) | -$300.00 K(+50.0%) |
| Mar 1993 | - | -$200.00 K | -$200.00 K |
| Dec 1992 | -$300.00 K(0.0%) | - | - |
| Dec 1991 | -$300.00 K(<-9900.0%) | - | - |
| Dec 1990 | $0.00 | - | - |
FAQ
- What is Fresh Tracks Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics annual CFI year-on-year change?
- What is Fresh Tracks Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics quarterly CFI year-on-year change?
- What is Fresh Tracks Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics TTM CFI year-on-year change?
What is Fresh Tracks Therapeutics annual cash flow from investing activities?
The current annual CFI of FRTX is $0.00
What is the all time high annual CFI for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high annual cash flow from investing activities is $42.93 M
What is Fresh Tracks Therapeutics annual CFI year-on-year change?
Over the past year, FRTX annual cash flow from investing activities has changed by +$47.00 K (+100.00%)
What is Fresh Tracks Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of FRTX is $0.00
What is the all time high quarterly CFI for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high quarterly cash flow from investing activities is $30.40 M
What is Fresh Tracks Therapeutics quarterly CFI year-on-year change?
Over the past year, FRTX quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Fresh Tracks Therapeutics TTM cash flow from investing activities?
The current TTM CFI of FRTX is $0.00
What is the all time high TTM CFI for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high TTM cash flow from investing activities is $52.55 M
What is Fresh Tracks Therapeutics TTM CFI year-on-year change?
Over the past year, FRTX TTM cash flow from investing activities has changed by $0.00 (0.00%)